AB-101, an Off-the-Shelf NK Cell Therapy Administered in an Outpatient Community Rheumatology Practice, Is More Cost-Effective Than CAR-T Treatments for Rheumatologic Diseases

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Nicholas J. Veomett, Subhashis Banerjee, Michael B. Saddekni, Feng Xu, Chris Horan, Kathy Perez, Guillermo Valenzuela

DOI: 10.1016/j.jtct.2025.12.469

Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Health Systems Economic Evaluations Quality of Life Rheumatoid Arthritis Research and Therapies